The Effect of Vasopressin on 90-Day Mortality in Patients With Cardiogenic Shock: A Retrospective Cohort Study Using Propensity Score-Weighted Analysis
Conclusion: Vasopressin was not associated with 30-day mortality and SAEs in patients with CS.
Saved in:
| Main Authors: | Christophe Beyls, Thomas Hanquiez, Nicolas Mollet, Yoni Sarfati, Adel Zerima, Souheil Chafiki, Patricia Besserve, Hervé Dupont, Momar Diouf, Osama Abou-Arab, Yazine Mahjoub |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Cardiovascular Therapeutics |
| Online Access: | http://dx.doi.org/10.1155/cdr/9920490 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of a virtual reality program on patient comfort in the surgical intensive care unit of a French university hospital: study protocol for a monocentric, prospective, superiority, randomised controlled trial–ZION study
by: Osama Abou-Arab, et al.
Published: (2025-07-01) -
Vasopressin Is Not Associated With Severe Kidney Injury in Liver Transplantation: A Propensity Score-adjusted Analysis
by: Edoardo Antonucci, MD, et al.
Published: (2025-06-01) -
2^nd^ Swiss Vasopressin Consensus: Vasopressin in Septic Shock and other Vasodilatory States
by: Karim Bendjelid, et al.
Published: (2025-06-01) -
Vasopressin: a review of clinical indications
by: Gregory Oliva, et al.
Published: (2025-03-01) -
Transient Central Diabetes Insipidus after Discontinuation of Vasopressin
by: Nathaniel Carman, et al.
Published: (2019-01-01)